ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors
SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
Dun & Bradstreet Honours Public Sector Excellence at the PSU & Government Summit 2025
MUMBAI, India, Oct. 23, 2025 /PRNewswire/ -- Dun & Bradstreet, a leading…
Alps Blockchain Announces Corporate Rebranding to Alps
Reflecting its evolution into a global builder of next-generation data center infrastructure…
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc.…
Inveniam and MANTRA Unveil Inveniam Chain: A Layer 2 Blockchain for the Management and Utilization of Private Real Estate Assets
ABU DHABI, UAE and DUBAI, UAE and NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Inveniam…
IIFL Finance Engages Leegality's Consentin for DPDP Compliance
IIFL Finance, one of India’s leading financial institutions, has engaged with Consentin…
Benchling Partners with Anthropic to Build a Bridge Between Science and AI
Claude's Life Sciences Ecosystem pairs Benchling AI with advanced reasoning in Claude…
Dun & Bradstreet Showcases India’s Strategic Edge at the GCC Summit 2025
MUMBAI, India, Oct. 16, 2025 /PRNewswire/ -- Dun & Bradstreet, a leading…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…